SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 408.00 |
| Enterprise Value ($M) | 466.95 |
| Book Value ($M) | -50.40 |
| Book Value / Share | -0.23 |
| Price / Book | -8.09 |
| NCAV ($M) | -157.42 |
| NCAV / Share | -0.72 |
| Price / NCAV | -2.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.87 |
| Return on Assets (ROA) | -0.19 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.21 |
| Current Ratio | 1.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 100.12 |
| Assets | 207.14 |
| Liabilities | 257.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BlackRock, Inc. | 7.20 | 0.00 | |
| 13G/A | Vanguard Group Inc | 4.04 | -32.31 | |
| 13G/A | Satter Muneer A | 8.60 | 7.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 488,765 | 2,024,747 | 24.14 | |
| 1,134,740 | 3,827,267 | 29.65 | |
| 394,739 | 2,058,743 | 19.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGEN – Agenus Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. | ALBT – Avalon GloboCare Corp. |
| ALDX – Aldeyra Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io